Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine and Compound Glutamine Enema via TET for Ulcerative Colitis
NCT03917095Unknown
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- May 2019
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of Salcrozine and glutamine in ulcerative colitis (UC) (5 arms), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoints: Clinical remission efficacy rate at 10 days and The effective rate at 10 days. Status: unknown.
02
Drugs
Salcrozineglutamine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03917095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03917095.